Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eberhard Ritz

Showing results (231-240 of 334) with videos related to

Pageof 34
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 31, 2007
Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) StudyEberhard Ritz, Maurice Laville, Rudy W Bilous, et al.
The New England Journal of Medicine|July 22, 2005
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysisChristoph Wanner, Vera Krane, Winfried März, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 4, 2009
Interstitial fibrosis and microvascular disease of the heart in uremia: amelioration by a calcimimeticNadezda Koleganova, Grzegorz Piecha, Eberhard Ritz, et al.
Kidney & Blood Pressure Research|August 1, 2015
Administration of Cyclosporine A in Pregnant Rats - the Effect on Blood Pressure and on the Glomerular Number in Their OffspringNatalia Slabiak-Blaz, Marcin Adamczak, Nadezda Gut, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2014
Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKDGerald Schulman, Tomas Berl, Gerald J Beck, et al.
Journal of the American Society of Nephrology : JASN|January 16, 2009
Avosentan reduces albumin excretion in diabetics with macroalbuminuriaRené R Wenzel, Thomas Littke, Susan Kuranoff, et al.
Kidney International|December 5, 2008
Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD StudyBenjamin Dieplinger, Thomas Mueller, Barbara Kollerits, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 12, 2009
Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies--the effect on podocytesZalan Nemeth, Gabor Kokeny, Maria Godo, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 19, 2003
Renal damage in the SHR/N-cp type 2 diabetes model: comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blockerMarie-Luise Gross, Eberhard Ritz, Arne Schoof, et al.
Expert Opinion on Pharmacotherapy|March 5, 2013
Cinacalcet hydrochloride for the treatment of hyperparathyroidismNicolas Verheyen, Stefan Pilz, Kathrin Eller, et al.
Pageof 34

Showing results (231-240 of 334) with videos related to

Sort By:
Pageof 34
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 31, 2007
Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) StudyEberhard Ritz, Maurice Laville, Rudy W Bilous, et al.
The New England Journal of Medicine|July 22, 2005
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysisChristoph Wanner, Vera Krane, Winfried März, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 4, 2009
Interstitial fibrosis and microvascular disease of the heart in uremia: amelioration by a calcimimeticNadezda Koleganova, Grzegorz Piecha, Eberhard Ritz, et al.
Kidney & Blood Pressure Research|August 1, 2015
Administration of Cyclosporine A in Pregnant Rats - the Effect on Blood Pressure and on the Glomerular Number in Their OffspringNatalia Slabiak-Blaz, Marcin Adamczak, Nadezda Gut, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2014
Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKDGerald Schulman, Tomas Berl, Gerald J Beck, et al.
Journal of the American Society of Nephrology : JASN|January 16, 2009
Avosentan reduces albumin excretion in diabetics with macroalbuminuriaRené R Wenzel, Thomas Littke, Susan Kuranoff, et al.
Kidney International|December 5, 2008
Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD StudyBenjamin Dieplinger, Thomas Mueller, Barbara Kollerits, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 12, 2009
Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies--the effect on podocytesZalan Nemeth, Gabor Kokeny, Maria Godo, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 19, 2003
Renal damage in the SHR/N-cp type 2 diabetes model: comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blockerMarie-Luise Gross, Eberhard Ritz, Arne Schoof, et al.
Expert Opinion on Pharmacotherapy|March 5, 2013
Cinacalcet hydrochloride for the treatment of hyperparathyroidismNicolas Verheyen, Stefan Pilz, Kathrin Eller, et al.
Pageof 34